Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

7.92
+0.01000.13%
Post-market: 7.920.00000.00%19:43 EDT
Volume:1.05M
Turnover:8.34M
Market Cap:1.07B
PE:29.77
High:8.05
Open:7.90
Low:7.81
Close:7.91
Loading ...

TMX Group Limited Announces Amended and Restated Agreement for Amalgamation with Bitcoin Treasury Corporation

Reuters
·
18 Jun

Gryphon Digital Mining Inc. Updates Agreement, Partners with 2703444 Alberta Ltd. for Strategic Acquisition of Captus Entities

Reuters
·
05 Jun

TMX Group Limited Announces Conditional Acceptance of Listing for Resulting Issuer Following Amalgamation with Bitcoin Treasury Corporation

Reuters
·
31 May

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

Zacks
·
30 May

Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study

TIPRANKS
·
22 May

New Aurora 1 Analysis: Lupkynis-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

THOMSON REUTERS
·
22 May

Aurinia Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Kathleen Goetz

Reuters
·
17 May

Stock Track | Aurinia Pharmaceuticals Soars 6.88% Pre-Market on Strong Q1 Earnings and Reaffirmed Guidance

Stock Track
·
16 May

Oberon Uranium Corp. Announces Agreement to Sell Saskatchewan Mineral Claims to Little Fish Uranium Corp

Reuters
·
16 May

EverGen Infrastructure Corp. Receives Final TSXV Approval for Real Property Sale and Updates Financing Plans

Reuters
·
15 May

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

Benzinga
·
13 May

Stock Track | Aurinia Pharmaceuticals Soars 6.88% Pre-Market on Strong Q1 Earnings and Reaffirmed Guidance

Stock Track
·
12 May

Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance

MT Newswires Live
·
12 May

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.16, vs. FactSet Est of $0.14

MT Newswires Live
·
12 May

Aurinia Pharmaceuticals Q1 EPS $0.16 Beats $0.10 Estimate, Sales $62.47M Beat $61.54M Estimate

Benzinga
·
12 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Press Release: Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Dow Jones
·
12 May

Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
10 May

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

THOMSON REUTERS
·
05 May

Glass Lewis Recommends That Aurinia Shareholders Vote “for” All Proposals at 2025 Annual General Meeting

THOMSON REUTERS
·
30 Apr